Prognostic and Predictive Molecular Markers in Cholangiocarcinoma

Area of Science:

• Oncology
• Gastroenterology
• Molecular Biology

Background:

• Cholangiocarcinoma (CCA) is a heterogeneous biliary tract cancer with increasing global mortality.
• Proximal extrahepatic CCA is the most common subtype in Western countries.
• Current prognostic factors like lymph node status are imperfect.

Purpose of the Study:

• To review known molecular prognostic and predictive markers in Cholangiocarcinoma.
• To highlight the role of these markers in patient management and risk stratification.
• To provide an overview for clinicians and researchers in the field.

Main Methods:

• Literature review of studies on molecular markers in Cholangiocarcinoma.
• Analysis of identified markers for prognostic and predictive value.
• Synthesis of findings regarding marker utility in clinical practice.

Main Results:

• Several molecular markers show potential for improving CCA prognostication.
• These markers can aid in identifying patients at high risk of recurrence.
• Molecular markers may refine treatment selection for surgical and palliative strategies.

Conclusions:

• Molecular markers offer adjuncts to traditional staging for Cholangiocarcinoma.
• Accurate prognostication through molecular markers can personalize patient care.
• Further research is needed to fully integrate these markers into clinical guidelines.